NEW YORK, Oct. 30, 2018 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) announced today that the next stage of development for its CD33 ARC (Antibody Radiation Conjugate) ...

WHITE PLAINS, N.Y., Sept. 20, 2012 /PRNewswire/ -- Thanks to support funding from The Leukemia & Lymphoma Society (LLS), Onconova Therapeutics, Inc. has been advancing rigosertib, the lead compound ...

(Logo: http://www.newscom.com/cgi-bin/prnh/20091117/DA12265LOGO) The program was sponsored in part by a $2.7 million federal educational grant received through the ...

This in-person session titled, "Practical Strategies for Optimizing Outcomes in MDS and AML," will be held on Sept. 8, 2026, from 3 to 5 pm CST, and will feature case-based discussions. The session ...